Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1055/s-0034-1373792 http://scihub22266oqcxt.onion/10.1055/s-0034-1373792 C4078175!4078175!25071304     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Semin+Intervent+Radiol 2014 ; 31 (2): 180-6 Nephropedia Template TP {{tp|p=25071304|t=2014. Image-Guided Percutaneous Ablation of Hepatic Malignancies |pdf=|usr=}}{{25071304}} gab.com Text Image-Guided Percutaneous Ablation of Hepatic Malignancies JO: Semin Intervent Radiol http://www.kidney.de/pget.php?&tw=1&pmid=25071304 #FOAvip The liver is a common site of primary and secondary malignancies, often resulting in significant morbidity and mortality. Evaluating these patients in a multidisciplinary setting allows for optimal utilization of all oncologic therapies including surgery, radiation, systemic chemotherapy, transarterial therapies, and ablation. While surgical intervention often provides the best outcomes when treating most hepatic tumors, many patients are not surgical candidates due to extensive tumor burden, underlying liver disease, or other comorbid conditions. The evolution of imaging and ablation devices has allowed for the increased utilization of percutaneous ablation as definitive and palliative treatment of primary and metastatic hepatic malignancies. Ablation induces tumor necrosis by injection of chemicals (chemical ablation) or temperature modification (thermal ablation). The goal of this review is to provide an overview of different ablation techniques commonly used for hepatic malignancies, discuss the oncologic outcomes of these interventions, and outline the current indications, contraindications, and reported complications of these therapies. Twit Text FOAVip Image-Guided Percutaneous Ablation of Hepatic Malignancies ????Semin Intervent Radiol http://www.kidney.de/pget.php?&tw=1&pmid=25071304 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25071304 #FOAvip English Wikipedia <ref>{{Cite pmid|25071304}}</ref> Image-Guided Percutaneous Ablation of Hepatic Malignancies #MMPMID25071304 Foltz G Semin Intervent Radiol 2014[Jun]; 31 (2): 180-6 PMID25071304show ga The liver is a common site of primary and secondary malignancies, often resulting in significant morbidity and mortality. Evaluating these patients in a multidisciplinary setting allows for optimal utilization of all oncologic therapies including surgery, radiation, systemic chemotherapy, transarterial therapies, and ablation. While surgical intervention often provides the best outcomes when treating most hepatic tumors, many patients are not surgical candidates due to extensive tumor burden, underlying liver disease, or other comorbid conditions. The evolution of imaging and ablation devices has allowed for the increased utilization of percutaneous ablation as definitive and palliative treatment of primary and metastatic hepatic malignancies. Ablation induces tumor necrosis by injection of chemicals (chemical ablation) or temperature modification (thermal ablation). The goal of this review is to provide an overview of different ablation techniques commonly used for hepatic malignancies, discuss the oncologic outcomes of these interventions, and outline the current indications, contraindications, and reported complications of these therapies. äImage-Guided Percutaneous Ablation of Hepatic Malignancies (epmc).pdf DeepDyve Pubget Overpricing